Literature DB >> 33752169

TRK inhibition in cholangiocarcinoma: Trying to teach an old dog new tricks.

Alessandro Rizzo1, Giovanni Brandi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33752169     DOI： 10.1016/j.ctarc.2021.100351

Source DB:  PubMed          Journal:  Cancer Treat Res Commun        ISSN： 2468-2942


× No keyword cloud information.
  2 in total

Review 1.  Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma.

Authors:  Su Min Cho; Abdullah Esmail; Ali Raza; Sunil Dacha; Maen Abdelrahim
Journal:  Cancers (Basel)       Date:  2022-05-26       Impact factor: 6.575

Review 2.  Targeted Therapies in Advanced Cholangiocarcinoma: A Focus on FGFR Inhibitors.

Authors:  Alessandro Rizzo
Journal:  Medicina (Kaunas)       Date:  2021-05-08       Impact factor: 2.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.